Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stevens

Showing results (1261-1270 of 1,367) with videos related to

Pageof 137
Sort By:
Nature|March 28, 2014
Structure of the human P2Y12 receptor in complex with an antithrombotic drugKaihua Zhang, Jin Zhang, Zhan-Guo Gao, et al.
Journal of Medicinal Chemistry|April 21, 2001
Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agentS D Larsen, M A Connell, M M Cudahy, et al.
Nature|May 18, 2017
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulatorsGaojie Song, Dehua Yang, Yuxia Wang, et al.
Nature|January 5, 2018
Structure of the glucagon receptor in complex with a glucagon analogueHaonan Zhang, Anna Qiao, Linlin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2018
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydesJulie P Saiki, Hongbin Cao, Lauren D Van Wassenhove, et al.
Histopathology|February 13, 2023
Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult populationEva A M Hesius, Lidia van Laar, Margriet Oosterveld, et al.
The Lancet. Infectious Diseases|July 24, 2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trialDavid A Margolis, Cynthia C Brinson, Graham H R Smith, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Cell Reports|December 5, 2019
Molecular Mechanism for Ligand Recognition and Subtype Selectivity of α<sub>2C</sub> Adrenergic ReceptorXiaoyu Chen, Yueming Xu, Lu Qu, et al.
The Lancet. Oncology|January 12, 2019
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup studyJacoline E C Bromberg, Samar Issa, Katerina Bakunina, et al.
Pageof 137

Showing results (1261-1270 of 1,367) with videos related to

Sort By:
Pageof 137
Nature|March 28, 2014
Structure of the human P2Y12 receptor in complex with an antithrombotic drugKaihua Zhang, Jin Zhang, Zhan-Guo Gao, et al.
Journal of Medicinal Chemistry|April 21, 2001
Synthesis and biological activity of analogues of the antidiabetic/antiobesity agent 3-guanidinopropionic acid: discovery of a novel aminoguanidinoacetic acid antidiabetic agentS D Larsen, M A Connell, M M Cudahy, et al.
Nature|May 18, 2017
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulatorsGaojie Song, Dehua Yang, Yuxia Wang, et al.
Nature|January 5, 2018
Structure of the glucagon receptor in complex with a glucagon analogueHaonan Zhang, Anna Qiao, Linlin Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2018
Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydesJulie P Saiki, Hongbin Cao, Lauren D Van Wassenhove, et al.
Histopathology|February 13, 2023
Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult populationEva A M Hesius, Lidia van Laar, Margriet Oosterveld, et al.
The Lancet. Infectious Diseases|July 24, 2015
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trialDavid A Margolis, Cynthia C Brinson, Graham H R Smith, et al.
Genes and Immunity|July 25, 2008
MAST3: a novel IBD risk factor that modulates TLR4 signalingC Labbé, P Goyette, C Lefebvre, et al.
Cell Reports|December 5, 2019
Molecular Mechanism for Ligand Recognition and Subtype Selectivity of α<sub>2C</sub> Adrenergic ReceptorXiaoyu Chen, Yueming Xu, Lu Qu, et al.
The Lancet. Oncology|January 12, 2019
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup studyJacoline E C Bromberg, Samar Issa, Katerina Bakunina, et al.
Pageof 137